Oppenheimer Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $750

Benzinga · 1d ago
Oppenheimer analyst Jay Olson maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $250 to $750.